Skip to content
DraconiticResearch
Search Sources API
210,423 studies31 sourcesUpdated 52 min ago

Oncology

5,311 studies490 in 7 days2,547 in 30 days

Filters
Type
Date
Clear

Latest

5,311 studies

  1. Early onset blood cancer risks associated with living near Superfund sites
    Haokun Yuan, Mary Beth Terry, Wan Yang
    JNCI Cancer SpectrumPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  2. The Impact of Bias Mitigation on Fairness and Accuracy in Automated Skin Lesion Classification
    Matheus B. Rocha, Renato A. Krohling
    Journal of healthcare informatics researchPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  3. Vitality as a Prognostic Biomarker in Hematologic Malignancies: Association With Overall Survival and Progression-Free Survival.
    Humberto Martínez Cordero, Laura C Bermúdez Rojas, Dolli Y Cáceres Gálindez +1
    CureusPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  4. Transcriptional networks underlying tumour plasticity in small-cell lung cancer
    D. Bhattacharya, S. M. Groves, C. Walker +9
    bioRxivPreprintCC BYFull textOncologybioRxiv
  5. Integrated immunopeptidomics and transcriptomics reveal a cancer-restricted non-canonical HLA class I ligandome in medulloblastoma
    A. Hui, N. Zheng, Y. Xu +1
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  6. A druggable chromatin vulnerability in suppressive neutrophils restores antitumor immunity
    F. Yang, Y. Bao, Y. Qiao +29
    bioRxivPreprintCC BYFull textOncologybioRxiv
  7. Systemic tumor-cell reprogramming converts solid tumors into in situ biofactories for immunotherapy
    S. Wang, Q. Xu, M. Wu +5
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  8. PGG Enhances Olaparib Efficacy via cGAS-STING Signaling and Sensitizes Triple-Negative Breast Cancer to PD- L1 Blockade
    h. S. Liu, X. Li, c. X. Yang +4
    bioRxivPreprintCC BYFull textOncologybioRxiv
  9. Can Molecular Response Redefine Organ Preservation in Rectal Cancer? From Clinical Complete Response to Precision Watch-and-Wait.
    Orçun Yalav, Ali Yıldırım, Natavan Guliyeva +5
    Medicina (Kaunas, Lithuania)Peer-reviewedCC BYFull textOncologyEurope PMC
  10. Functional Deconstruction of AC-T Chemotherapy Reveals Interindividual Heterogeneity and Independent Drug Action in Breast Cancer.
    Lucas Damé Simões, Giulia Luiza Santos, Priscila Oliveira de Carvalho +17
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  11. OVO-like Proteins in Cancer, Immunity, and Inflammation.
    Shuxian Huang, Genjian Hu, Hao Lan +1
    CellsPeer-reviewedCC BYFull textOncologyEurope PMC
  12. Uncovering Immune Cell-Specific lncRNAs as Anti-PD-1 Response-Associated Markers in Breast Cancer.
    Clayton Voidelo, Thalita Maria do Nascimento, Regiane Stafim da Cunha +2
    International journal of molecular sciencesPeer-reviewedCC BYFull textOncologyEurope PMC
  13. Enrichment-Free Rare Cell Profiling in Pediatric Osteosarcoma Reveals a Circulating Cell Population Associated with Relapse-Free Survival
    Stephanie N. Shishido, Siddhant Chaudhary, Ian Ward +7
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  14. The Landscape of Tumor Dissemination in Leptomeningeal Disease: Mapping CTC Plasticity and Regional Heterogeneity Across Blood and CSF Compartments
    Stephanie N. Shishido, Baishali Chaudhuri, Vidur Mushran +7
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  15. PLIN2 links lipid droplets to GRP78-mediated GPX4 stabilization to suppress neuronal ferroptosis
    Qianruo Wang, Baokun Sui, Jiaxin Zheng +5
    Cell InsightPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  16. Cancer Neuroscience: Establishing a home in Neuro-Oncology
    Shawn L Hervey-Jumper, Michelle Monje, Frank Winkler +1
    Neuro-OncologyPeer-reviewedPublisher termsFull textOncologyPMC
  17. Glioma and ependymoma through the lens of brain development, stem cells, and plasticity
    Costanza Lo Cascio, Antoni Martija, Mariella G Filbin +1
    Neuro-OncologyPeer-reviewedPublisher termsFull textOncologyPMC
  18. Integrated EBV and host DNA methylation profiling identifies distinct candidate EBV–host junction patterns in chronic active EBV infection
    Ran Wang, Linlin Zhang, Dilara Dilmurat +8
    Microbiology SpectrumPeer-reviewedCC BY 4.0Full textOncologyPMC
  19. Liquid Biopsy and Multi‐Cancer Early Detection Tests for Cancer Screening: A Scoping Review
    Tessa Robinson, Marian Saab, Lily Thao Nguyen +4
    Clinical GeneticsPeer-reviewedCC BY 4.0Full textOncologyPMC
  20. Multipronged enhancement of CART cell activity against ROR1 neoantigen by inhibition of H3K27 methyltransferase EZH2
    Shengchun Wang, Cosimo Lobello, Pradeep K. Gupta +21
    Cell Reports MedicinePeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  21. Accelerating equitable cancer genomics and precision oncology in health care and research: a Lancet Oncology Commission
    Raffaella Casolino, Joaquı́n Mateo, Elisabeth G E de Vries +53
    The Lancet OncologyPeer-reviewedLicence not stated10 citedOncologyOpenAlex
  22. Disruption of the ARID1A-containing SWI/SNF complex reprograms tumor-associated macrophages and enhances immunotherapy response
    H. M. McRae, K. M. Nguyen, Q. Vallmajo-Martin +13
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  23. Palmitate-activated IRE1-XBP1 signaling limits DNA damage and is associated with H2A.X-linked DNA damage response transcripts in triple-negative breast cancer cells
    K. Y. Chen, E. Gouin, A. Erickson +6
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  24. Deciphering the association of spatial landscapes of DCIS with recurrence as invasive breast cancer
    N. Graham, A. K. Turnbull, C. Martinez-Perez +3
    bioRxivPreprintCC BYFull textOncologybioRxiv
  25. Pathway-wide base editing charts chemical-genetic interactions in MAPK signaling
    J. Woods, C. X. Y. Hu, D. M. Jang +6
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv